These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vaccine Development for Zika Virus-Timelines and Strategies. Durbin AP Semin Reprod Med; 2016 Sep; 34(5):299-304. PubMed ID: 27607566 [TBL] [Abstract][Full Text] [Related]
3. [Advances in Zika vaccines]. Wang R; Chen H; An J Wei Sheng Wu Xue Bao; 2017 Feb; 57(2):188-96. PubMed ID: 29750481 [TBL] [Abstract][Full Text] [Related]
4. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models. Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661 [TBL] [Abstract][Full Text] [Related]
5. Zika virus structural biology and progress in vaccine development. Lin HH; Yip BS; Huang LM; Wu SC Biotechnol Adv; 2018; 36(1):47-53. PubMed ID: 28916391 [TBL] [Abstract][Full Text] [Related]
6. An update on Zika vaccine developments. Durbin A; Wilder-Smith A Expert Rev Vaccines; 2017 Aug; 16(8):781-787. PubMed ID: 28633549 [TBL] [Abstract][Full Text] [Related]
7. Challenges of Vaccine Development for Zika Virus. Blackman MA; Kim IJ; Lin JS; Thomas SJ Viral Immunol; 2018 Mar; 31(2):117-123. PubMed ID: 29227202 [TBL] [Abstract][Full Text] [Related]
8. A Glimmer of Hope: Recent Updates and Future Challenges in Zika Vaccine Development. Castanha PMS; Marques ETA Viruses; 2020 Nov; 12(12):. PubMed ID: 33266129 [TBL] [Abstract][Full Text] [Related]
11. Clinical Development Strategies and Considerations for Zika Vaccine Licensure. Gruber MF; Farizo KM; Pratt RD; Fink DL; Finn TM; Krause PR; Borio LL; Marks PW J Infect Dis; 2017 Dec; 216(suppl_10):S964-S970. PubMed ID: 29267913 [TBL] [Abstract][Full Text] [Related]
12. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage. Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice. Lecouturier V; Bernard MC; Berry C; Carayol S; Richier E; Boudet F; Heinrichs J Vaccine; 2019 May; 37(20):2679-2686. PubMed ID: 30967310 [TBL] [Abstract][Full Text] [Related]
14. A Literature Review of Zika Virus. Plourde AR; Bloch EM Emerg Infect Dis; 2016 Jul; 22(7):1185-92. PubMed ID: 27070380 [TBL] [Abstract][Full Text] [Related]
15. Zika Vaccines: Role for Controlled Human Infection. Durbin AP; Whitehead SS J Infect Dis; 2017 Dec; 216(suppl_10):S971-S975. PubMed ID: 29267920 [TBL] [Abstract][Full Text] [Related]
16. Drugs for the Treatment of Zika Virus Infection. Bernatchez JA; Tran LT; Li J; Luan Y; Siqueira-Neto JL; Li R J Med Chem; 2020 Jan; 63(2):470-489. PubMed ID: 31549836 [TBL] [Abstract][Full Text] [Related]
17. Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency. Vannice KS; Giersing BK; Kaslow DC; Griffiths E; Meyer H; Barrett A; Durbin AP; Wood D; Hombach J Vaccine; 2019 Nov; 37(50):7443-7450. PubMed ID: 27916410 [TBL] [Abstract][Full Text] [Related]